Trial Profile
Safety and efficacy of bazedoxifene in postmenopausal women with osteoporosis and osteopenia: A prospective pilot study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2018
Price :
$35
*
At a glance
- Drugs Bazedoxifene (Primary)
- Indications Metabolic bone diseases; Postmenopausal osteoporosis
- Focus Adverse reactions; Therapeutic Use
- 06 Oct 2018 Results presented at the North American Menopause Society 2018 Annual Meeting
- 19 Jan 2018 New trial record